Clinical trial Recruiting at 1 site Observational Ages 18 and up

Pulsed field ablation registry for atrial arrhythmias in Poland.

Official title: Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland

Run by Wroclaw Medical University · NCT07109141 · Data updated 2026-11-12

This project will collect information to see how well pulsed field ablation works and how safe it is for people in Poland having ablation for atrial fibrillation, atrial flutter, or atrial tachycardia.

More Atrial Fibrillation (AF) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorWroclaw Medical University
Academic / other
Locations1 site (Wroclaw, Lower Silesian Voivodeship)
StatusRecruiting
StartedAugust 1, 2024
Main results expectedJuly 1, 2030
Study endsJuly 1, 2030
Registry record updatedAugust 7, 2025
Trial IDNCT07109141 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults in Poland who are undergoing pulsed field ablation for atrial arrhythmias (including atrial fibrillation, atrial flutter, or atrial tachycardia) and can give informed consent.

Probably not a fit

Patients who are not treated with PFA (for example those receiving conventional thermal ablation), those with ventricular arrhythmias only, or those who do not consent are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Pulsed field ablation (PFA) is a relatively new, tissue‑selective catheter technique based on irreversible electroporation that has shown safety and efficacy for pulmonary vein isolation in paroxysmal atrial fibrillation. This multicenter, nationwide registry will gather standardized clinical and procedural data from patients undergoing PFA for atrial arrhythmias outside the pulmonary veins, such as atrial flutter and atrial tachycardia. The registry will consolidate outcomes on procedural success, complications, and operator techniques to characterize real‑world use across Polish centers. Data from the registry are intended to inform best practices and support the planning of future randomized trials.

Why it matters

Potential benefit: If successful, the registry could improve understanding of PFA safety and effectiveness for non‑pulmonary‑vein atrial arrhythmias and help refine techniques and patient selection.

How similar studies have gone: Previous clinical studies have shown PFA to be effective and safe for pulmonary vein isolation in paroxysmal AF, but systematic evidence for its use in other atrial arrhythmias is limited and largely anecdotal.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed consent obtained from the participant
* Subject is undergoing ablation of an atrial arrhythmia using the PFA

Exclusion Criteria:

\-

Where it's running

  • Clinical Department of Cardio, Jan Mikulicz Radecki University Hospital in Wroclaw
    Wroclaw, Lower Silesian Voivodeship, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.